---

Herbal medicated gummies: A flange approach in management of depression and anxiety

---

Review Article

Author Details : Payaam Vohra*, Sunanda Patil, Walia Khan

Volume : 10, Issue : 1, Year : 2023

Article Page : 17-19

https://doi.org/10.18231/j.ijpp.2023.005

Suggest article by email

Get Permission

---

Abstract

According to WHO Depression is a common internal complaint. Encyclopedically, it's estimated that 264 million of grown-ups suffer from depression. Depression is a leading cause of disability worldwide and is a major contributor to the overall global burden of complaint. This exploration totally focuses upon formulating a drug for people suffering from depression in a fascinating and fluently respectable way. The condition of depression has worsen post epidemic with increase in number of cases associated with youth. This paper briefly discusses preface of the antidepressant sauces in a sticky form. Flavonoid and associated phytochemicals exerts an antidepressant effect via modulation of central noradrenaline(NA), dopamine(DA), serotonin(5- HT), and ?- amino butyric acid(GABA) neurotransmission. Turmeric specifically, curcumin could be a mainstream depression treatment. A combination of Turmeric, Tulsi and chamomile can prove to be a boon for operation of Depression with minimum side goods. This medicine delivery system provides fresh patient benefits and compliance, offering several advantages over tablets or liquid phrasings in that, the remedial system isn't to be swallowed and this increases patient compliance, especially for elders and pediatrics with swallowing diseases; also, the product can be taken anywhere and at any time as it doesn't bear liquids to prop swallowing. This expression seems to be a promising combination of the sauces for productive operation of depression and anxiety.

Keywords: Herbal gummies, Antidepressant, Case compliance, Pediatrics, Geriatrics

How to cite : Vohra P, Patil S, Khan W, Herbal medicated gummies: A flange approach in management of depression and anxiety. Indian J Pharm Pharmacol 2023;10(1):17-19

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.